Poolbeg Pharma PLC (POLBF)
OTCMKTS · Delayed Price · Currency is USD
0.0661
0.00 (0.00%)
At close: Feb 10, 2026
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of $45.14 million as of February 12, 2026. Its market cap has increased by 42.03% in one year.
Market Cap
45.14M
Enterprise Value
31.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 73.52M to 45.14M, a decrease of -38.60%. That is a compound annual growth rate of -10.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 44.25M | 17.90% |
| Dec 31, 2025 | 37.53M | -15.55% |
| Dec 31, 2024 | 44.44M | -22.89% |
| Dec 29, 2023 | 57.64M | 58.14% |
| Dec 30, 2022 | 36.45M | -43.33% |
| Dec 31, 2021 | 64.32M | -12.52% |
| Jul 19, 2021 | 73.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Cell Source | 41.50M |
| ZIVO Bioscience | 40.77M |
| Arch Biopartners | 38.73M |
| Harvard Apparatus Regenerative Technology | 31.65M |
| Oncotelic Therapeutics | 28.70M |